{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:49:34Z","timestamp":1789674574058,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jneuroim.2011.07.003","type":"journal-article","created":{"date-parts":[[2011,8,23]],"date-time":"2011-08-23T15:54:45Z","timestamp":1314114885000},"page":"81-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy"],"prefix":"10.1016","volume":"238","author":[{"given":"Daniel M.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Skolasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jneuroim.2011.07.003_bb0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/13550280152537184","article-title":"Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era","volume":"7","author":"Antinori","year":"2001","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.jneuroim.2011.07.003_bb0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.410440309","article-title":"Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy","volume":"44","author":"Berger","year":"1998","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2011.07.003_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/13550289809113482","article-title":"Progressive multifocal leukoencephalopathy in patients with HIV infection","volume":"4","author":"Berger","year":"1998","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.jneuroim.2011.07.003_bb0020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","article-title":"Progressive multifocal leukoencephalopathy","volume":"2","author":"Brooks","year":"1984","journal-title":"Neurol. Clin."},{"issue":"20","key":"10.1016\/j.jneuroim.2011.07.003_bb0025","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jneuroim.2011.07.003_bb0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/13550280152537247","article-title":"The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy","volume":"7","author":"Cinque","year":"2001","journal-title":"J. Neurovirol."},{"issue":"Suppl 1","key":"10.1016\/j.jneuroim.2011.07.003_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/13550280390195351","article-title":"The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature","volume":"9","author":"Cinque","year":"2003","journal-title":"J. Neurovirol."},{"issue":"3","key":"10.1016\/j.jneuroim.2011.07.003_bb0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/WNL.52.3.623","article-title":"HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy","volume":"52","author":"Clifford","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2011.07.003_bb0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2011.07.003_bb0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00003495-200868020-00004","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management","volume":"68","author":"Dhasmana","year":"2008","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jneuroim.2011.07.003_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study","volume":"199","author":"Engsig","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2011.07.003_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QAI.0b013e31817bec64","article-title":"Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study","volume":"49","author":"Falco","year":"2008","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"issue":"11","key":"10.1016\/j.jneuroim.2011.07.003_bb0065","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.41.11.1733","article-title":"Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data","volume":"41","author":"Holman","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jneuroim.2011.07.003_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000026184","article-title":"Progressive multifocal leukoencephalopathy in the United States, 1979\u20131994: increased mortality associated with HIV infection","volume":"17","author":"Holman","year":"1998","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.jneuroim.2011.07.003_bb0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.21085","article-title":"Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients","volume":"62","author":"Huang","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.07.003_bb0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1749-6632.2009.05111.x","article-title":"Neurological complications of immune reconstitution in HIV-infected populations","volume":"1184","author":"Johnson","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.jneuroim.2011.07.003_bb0085","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa0810316","article-title":"Progressive multifocal leukoencephalopathy after natalizumab monotherapy","volume":"361","author":"Linda","year":"2009","journal-title":"N Engl J. Med."},{"issue":"4","key":"10.1016\/j.jneuroim.2011.07.003_bb0090","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","article-title":"Immune reconstitution inflammatory syndrome: risk factors and treatment implications","volume":"46","author":"Manabe","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"9","key":"10.1016\/j.jneuroim.2011.07.003_bb0095","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/01.wnl.0000242728.26433.12","article-title":"Immune reconstitution inflammatory syndrome associated with PML in AIDS: a treatable disorder","volume":"67","author":"Martinez","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jneuroim.2011.07.003_bb0100","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1212\/01.wnl.0000343854.80344.69","article-title":"Neurologic immune reconstitution inflammatory syndrome in HIV\/AIDS: outcome and epidemiology","volume":"72","author":"McCombe","year":"2009","journal-title":"Neurology"},{"issue":"7712","key":"10.1016\/j.jneuroim.2011.07.003_bb0105","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","article-title":"Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy","volume":"1","author":"Padgett","year":"1971","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jneuroim.2011.07.003_bb0110","first-page":"1896","article-title":"Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team","volume":"20","author":"Post","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"8","key":"10.1016\/j.jneuroim.2011.07.003_bb0115","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/NEN.0b013e318181b4da","article-title":"Immune reconstitution inflammatory syndrome of the brain: case illustrations of a challenging entity","volume":"67","author":"Rushing","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2011.07.003_bb0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jneuroim.2011.07.003_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dki444","article-title":"Immune reconstitution inflammatory syndrome: more answers, more questions","volume":"57","author":"Shelburne","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"issue":"17","key":"10.1016\/j.jneuroim.2011.07.003_bb0130","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000343510.08643.74","article-title":"PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids","volume":"72","author":"Tan","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jneuroim.2011.07.003_bb0135","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archneurol.2010.315","article-title":"A clue to the pathophysiology of posterior reversible encephalopathy syndrome","volume":"67","author":"Thachil","year":"2010","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.jneuroim.2011.07.003_bb0140","first-page":"977","article-title":"Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy","volume":"22","author":"Thurnher","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"4","key":"10.1016\/j.jneuroim.2011.07.003_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-005-0983-y","article-title":"Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy","volume":"109","author":"Vendrely","year":"2005","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.jneuroim.2011.07.003_bb0150","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.expneurol.2004.08.008","article-title":"Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood\u2013brain barrier","volume":"190","author":"Wong","year":"2004","journal-title":"Exp. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811001937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811001937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:17:31Z","timestamp":1759047451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572811001937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0165572811001937"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.07.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}